Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 14/20 | 0.62 |
| ▸ | DRD2 | P14416 | 13/20 | 0.62 |
| ▸ | NAMPT | P43490 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7057467 | 1.00 | DRD3 (0.62) | DRD3DRD2NAMPTCYP3A4CYP2C9 | |
| SCHEMBL6266293 | 0.81 | DRD3 (0.72) | DRD3DRD2NAMPTCYP3A4CYP2C9 | |
| SCHEMBL6266296 | 0.81 | DRD3 (0.72) | DRD3DRD2NAMPTCYP3A4CYP2C9 | |
| SCHEMBL16462988 | 0.77 | DRD2 (1.00) | DRD3DRD2 | |
| SCHEMBL7055012 | 0.76 | DRD2 (0.65) | DRD3DRD2HTR1AHTR2A | |
| SCHEMBL7052681 | 0.75 | DRD3 (0.67) | DRD3DRD2 | |
| SCHEMBL7059254 | 0.75 | DRD3 (0.65) | DRD3DRD2HTR1AHTR2A | |
| Hydrochloric Acid SCHEMBL7053559 | 0.75 | NAMPT (0.56) | DRD3DRD2NAMPTCYP3A4CYP2C9 | |
| Hydrochloric Acid SCHEMBL7053563 | 0.75 | NAMPT (0.56) | DRD3DRD2NAMPTCYP3A4CYP2C9 | |
| SCHEMBL7050873 | 0.75 | DRD2 (0.67) | DRD3DRD2HTR1AHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003028728-A1 | 4-(4-SUBSTITUTED PIPERAZINYL-1YL)-BUTYLCARBOXAMIDES AS D3 DOPAMINE SUBTYPE SELECTIVE LIGANDS | Richter Gedeon Vegyészeti Gyár Rt. (HU) | 2003-04-10 | — | — | WO | disclosed |